Delivery Order SPE2DB22D3501-SPE2DB25FXB26
- Not listed
- The Defense Logistics Agency awarded a $82,059.20 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Menopur 75 Unit Vials. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is scheduled for completion by July 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,036.71 delivery order to AmerisourceBergen Drug Corp for Menopur 75 Unit Vials, with an ultimate completion date of July 24, 2025. This contract employs firm fixed pricing and was competitively awarded with no set-aside designation. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $19,980.83 to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit Vials. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive award under the company's existing contract vehicle with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $103,790.69 to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit Vials. This competitively awarded, firm fixed-price contract was executed on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $47,817.37 delivery order to AmerisourceBergen Drug Corp for MENOPUR 75 Unit Vials under a firm fixed-price contract. The order was competitively awarded with no set-aside designation and is scheduled for completion by July 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $43,836.60 for 75-unit vials of Menopur, a fertility medication, from the Defense Logistics Agency's Medical Supply Chain on August 27, 2025. The contract utilizes a firm fixed-price delivery order structure with an ultimate completion date of August 28, 2025. This award was made through competitive procedures without any set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a $24,529.17 delivery order to AmerisourceBergen Drug Corp for 75-unit vials of Menopur, a fertility medication used in assisted reproductive procedures. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 24, 2025, with performance to be completed in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This delivery order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $100,913.29 firm-fixed-price contract is for the supply of 4,565,055,511 units of Menopur 75 unit vials, with a period of performance through July 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This delivery order, issued on August 19, 2025, awards AmerisourceBergen Drug Corp $90,074.85 under a firm fixed price contract to supply Menopur 75 Unit vials to support federal medical procurement needs. The award is issued by the Defense Logistics Agency's Medical Supply Chain and is designated for delivery to the contractor's location in Conshohocken, Pennsylvania. This is a competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a prime contractor subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $6,204.42 contract is for the delivery of Menopur 75 unit vials, a specialty pharmaceutical product, to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXB26Delivery Order
The Defense Logistics Agency awarded a $58,448.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit Vials. The contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026, which serves as the primary pharmaceutical support vehicle for military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected for this award without set-aside designation. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. Menopur, a hormone treatment medication, aligns with AmerisourceBergen's established portfolio of specialty pharmaceuticals and brand-name medications delivered through the DLA's Medical Supply Chain to support Defense Health Agency and other government healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $58.4k | 8/27/25 |